Hualan Biological Bacterin Co. Ltd.   Report issue

For profit Phase 2 Phase 3
Founded: Xinxiang China (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2009
NCT00975572
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Hualan Biological Bacterin Co. Ltd.

Active Ingredients

Drugs in Phase 3 Trials (1)

Bivalent group A and C meningococcal vaccine (Menomune-A/C) (1 trial)

Drugs in Phase 2 Trials (1)

inactivated influenza vaccine (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Infections (Phase 2)

Influenza, Human (Phase 2)

Orthomyxoviridae Infections (Phase 2)

Respiratory Tract Diseases (Phase 2)

Respiratory Tract Infections (Phase 2)

Virus Diseases (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2